世界の血漿分画技術市場予測2023-2029:アルブミン、免疫グロブリン、凝固因子、その他

【英語タイトル】Blood Plasma Fractionation Technology Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが出版した調査資料(MMG23FB2163)・商品コード:MMG23FB2163
・発行会社(調査会社):Market Monitor Global
・発行日:2023年2月
・ページ数:102
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後2-3営業日)
・調査対象地域:グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,250 ⇒換算¥494,000見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD4,225 ⇒換算¥642,200見積依頼/購入/質問フォーム
Enterprise User(閲覧人数制限なし)USD4,875 ⇒換算¥741,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界の血漿分画技術市場規模と予測を収録しています。・世界の血漿分画技術市場:売上、2018年-2023年、2024年-2029年
・世界の血漿分画技術市場:販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の血漿分画技術市場は2022年に000Mドルと評価され、予測期間中に000%のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「アルブミン」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

血漿分画技術のグローバル主要企業は、Takeda、CSL、Grifols、Octapharma、Kedrion、LFB Group、Biotest、BPL、RAAS、CBPO、Hualan Bio、Tiantan Bio、Shuanglin Bio、Boya Bio、Yuanda Shuyang、Weiguang Bio、Nanyue Bio、KM Biologicsなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL(MMG)は、血漿分画技術のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の血漿分画技術市場:タイプ別、2018年-2023年、2024年-2029年
世界の血漿分画技術市場:タイプ別市場シェア、2022年
・アルブミン、免疫グロブリン、凝固因子、その他

世界の血漿分画技術市場:用途別、2018年-2023年、2024年-2029年
世界の血漿分画技術市場:用途別市場シェア、2022年
・病院、薬局、その他

世界の血漿分画技術市場:地域・国別、2018年-2023年、2024年-2029年
世界の血漿分画技術市場:地域別市場シェア、2022年
・北米:アメリカ、カナダ、メキシコ
・ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
・アジア:中国、日本、韓国、東南アジア、インド
・南米:ブラジル、アルゼンチン
・中東・アフリカ:トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における血漿分画技術のグローバル売上、2018年-2023年
・主要企業における血漿分画技術のグローバル売上シェア、2022年
・主要企業における血漿分画技術のグローバル販売量、2018年-2023年
・主要企業における血漿分画技術のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Takeda、CSL、Grifols、Octapharma、Kedrion、LFB Group、Biotest、BPL、RAAS、CBPO、Hualan Bio、Tiantan Bio、Shuanglin Bio、Boya Bio、Yuanda Shuyang、Weiguang Bio、Nanyue Bio、KM Biologics

*************************************************************

・調査・分析レポートの概要
血漿分画技術市場の定義
市場セグメント
世界の血漿分画技術市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の血漿分画技術市場規模
世界の血漿分画技術市場規模:2022年 VS 2029年
世界の血漿分画技術市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの血漿分画技術の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の血漿分画技術製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分:アルブミン、免疫グロブリン、凝固因子、その他
血漿分画技術のタイプ別グローバル売上・予測

・用途別市場分析
用途区分:病院、薬局、その他
血漿分画技術の用途別グローバル売上・予測

・地域別市場分析
地域別血漿分画技術市場規模 2022年と2029年
地域別血漿分画技術売上・予測
北米市場:アメリカ、カナダ、メキシコ
ヨーロッパ市場:ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場:中国、日本、韓国、東南アジア、インド
南米市場:ブラジル、アルゼンチン
中東・アフリカ市場:トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル(企業概要、事業概要、主要製品、売上、ニュースなど)
Takeda、CSL、Grifols、Octapharma、Kedrion、LFB Group、Biotest、BPL、RAAS、CBPO、Hualan Bio、Tiantan Bio、Shuanglin Bio、Boya Bio、Yuanda Shuyang、Weiguang Bio、Nanyue Bio、KM Biologics

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Blood Plasma Fractionation Technology Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Blood Plasma Fractionation Technology Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Blood Plasma Fractionation Technology Overall Market Size
2.1 Global Blood Plasma Fractionation Technology Market Size: 2022 VS 2029
2.2 Global Blood Plasma Fractionation Technology Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Blood Plasma Fractionation Technology Players in Global Market
3.2 Top Global Blood Plasma Fractionation Technology Companies Ranked by Revenue
3.3 Global Blood Plasma Fractionation Technology Revenue by Companies
3.4 Top 3 and Top 5 Blood Plasma Fractionation Technology Companies in Global Market, by Revenue in 2022
3.5 Global Companies Blood Plasma Fractionation Technology Product Type
3.6 Tier 1, Tier 2 and Tier 3 Blood Plasma Fractionation Technology Players in Global Market
3.6.1 List of Global Tier 1 Blood Plasma Fractionation Technology Companies
3.6.2 List of Global Tier 2 and Tier 3 Blood Plasma Fractionation Technology Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Blood Plasma Fractionation Technology Market Size Markets, 2022 & 2029
4.1.2 Albumin
4.1.3 Immune Globulin
4.1.4 Coagulation Factor
4.1.5 Others
4.2 By Type – Global Blood Plasma Fractionation Technology Revenue & Forecasts
4.2.1 By Type – Global Blood Plasma Fractionation Technology Revenue, 2018-2023
4.2.2 By Type – Global Blood Plasma Fractionation Technology Revenue, 2024-2029
4.2.3 By Type – Global Blood Plasma Fractionation Technology Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Blood Plasma Fractionation Technology Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Retail Pharmacy
5.1.4 Others
5.2 By Application – Global Blood Plasma Fractionation Technology Revenue & Forecasts
5.2.1 By Application – Global Blood Plasma Fractionation Technology Revenue, 2018-2023
5.2.2 By Application – Global Blood Plasma Fractionation Technology Revenue, 2024-2029
5.2.3 By Application – Global Blood Plasma Fractionation Technology Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Blood Plasma Fractionation Technology Market Size, 2022 & 2029
6.2 By Region – Global Blood Plasma Fractionation Technology Revenue & Forecasts
6.2.1 By Region – Global Blood Plasma Fractionation Technology Revenue, 2018-2023
6.2.2 By Region – Global Blood Plasma Fractionation Technology Revenue, 2024-2029
6.2.3 By Region – Global Blood Plasma Fractionation Technology Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Blood Plasma Fractionation Technology Revenue, 2018-2029
6.3.2 US Blood Plasma Fractionation Technology Market Size, 2018-2029
6.3.3 Canada Blood Plasma Fractionation Technology Market Size, 2018-2029
6.3.4 Mexico Blood Plasma Fractionation Technology Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Blood Plasma Fractionation Technology Revenue, 2018-2029
6.4.2 Germany Blood Plasma Fractionation Technology Market Size, 2018-2029
6.4.3 France Blood Plasma Fractionation Technology Market Size, 2018-2029
6.4.4 U.K. Blood Plasma Fractionation Technology Market Size, 2018-2029
6.4.5 Italy Blood Plasma Fractionation Technology Market Size, 2018-2029
6.4.6 Russia Blood Plasma Fractionation Technology Market Size, 2018-2029
6.4.7 Nordic Countries Blood Plasma Fractionation Technology Market Size, 2018-2029
6.4.8 Benelux Blood Plasma Fractionation Technology Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Blood Plasma Fractionation Technology Revenue, 2018-2029
6.5.2 China Blood Plasma Fractionation Technology Market Size, 2018-2029
6.5.3 Japan Blood Plasma Fractionation Technology Market Size, 2018-2029
6.5.4 South Korea Blood Plasma Fractionation Technology Market Size, 2018-2029
6.5.5 Southeast Asia Blood Plasma Fractionation Technology Market Size, 2018-2029
6.5.6 India Blood Plasma Fractionation Technology Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Blood Plasma Fractionation Technology Revenue, 2018-2029
6.6.2 Brazil Blood Plasma Fractionation Technology Market Size, 2018-2029
6.6.3 Argentina Blood Plasma Fractionation Technology Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Blood Plasma Fractionation Technology Revenue, 2018-2029
6.7.2 Turkey Blood Plasma Fractionation Technology Market Size, 2018-2029
6.7.3 Israel Blood Plasma Fractionation Technology Market Size, 2018-2029
6.7.4 Saudi Arabia Blood Plasma Fractionation Technology Market Size, 2018-2029
6.7.5 UAE Blood Plasma Fractionation Technology Market Size, 2018-2029
7 Blood Plasma Fractionation Technology Companies Profiles
7.1 Takeda
7.1.1 Takeda Company Summary
7.1.2 Takeda Business Overview
7.1.3 Takeda Blood Plasma Fractionation Technology Major Product Offerings
7.1.4 Takeda Blood Plasma Fractionation Technology Revenue in Global Market (2018-2023)
7.1.5 Takeda Key News & Latest Developments
7.2 CSL
7.2.1 CSL Company Summary
7.2.2 CSL Business Overview
7.2.3 CSL Blood Plasma Fractionation Technology Major Product Offerings
7.2.4 CSL Blood Plasma Fractionation Technology Revenue in Global Market (2018-2023)
7.2.5 CSL Key News & Latest Developments
7.3 Grifols
7.3.1 Grifols Company Summary
7.3.2 Grifols Business Overview
7.3.3 Grifols Blood Plasma Fractionation Technology Major Product Offerings
7.3.4 Grifols Blood Plasma Fractionation Technology Revenue in Global Market (2018-2023)
7.3.5 Grifols Key News & Latest Developments
7.4 Octapharma
7.4.1 Octapharma Company Summary
7.4.2 Octapharma Business Overview
7.4.3 Octapharma Blood Plasma Fractionation Technology Major Product Offerings
7.4.4 Octapharma Blood Plasma Fractionation Technology Revenue in Global Market (2018-2023)
7.4.5 Octapharma Key News & Latest Developments
7.5 Kedrion
7.5.1 Kedrion Company Summary
7.5.2 Kedrion Business Overview
7.5.3 Kedrion Blood Plasma Fractionation Technology Major Product Offerings
7.5.4 Kedrion Blood Plasma Fractionation Technology Revenue in Global Market (2018-2023)
7.5.5 Kedrion Key News & Latest Developments
7.6 LFB Group
7.6.1 LFB Group Company Summary
7.6.2 LFB Group Business Overview
7.6.3 LFB Group Blood Plasma Fractionation Technology Major Product Offerings
7.6.4 LFB Group Blood Plasma Fractionation Technology Revenue in Global Market (2018-2023)
7.6.5 LFB Group Key News & Latest Developments
7.7 Biotest
7.7.1 Biotest Company Summary
7.7.2 Biotest Business Overview
7.7.3 Biotest Blood Plasma Fractionation Technology Major Product Offerings
7.7.4 Biotest Blood Plasma Fractionation Technology Revenue in Global Market (2018-2023)
7.7.5 Biotest Key News & Latest Developments
7.8 BPL
7.8.1 BPL Company Summary
7.8.2 BPL Business Overview
7.8.3 BPL Blood Plasma Fractionation Technology Major Product Offerings
7.8.4 BPL Blood Plasma Fractionation Technology Revenue in Global Market (2018-2023)
7.8.5 BPL Key News & Latest Developments
7.9 RAAS
7.9.1 RAAS Company Summary
7.9.2 RAAS Business Overview
7.9.3 RAAS Blood Plasma Fractionation Technology Major Product Offerings
7.9.4 RAAS Blood Plasma Fractionation Technology Revenue in Global Market (2018-2023)
7.9.5 RAAS Key News & Latest Developments
7.10 CBPO
7.10.1 CBPO Company Summary
7.10.2 CBPO Business Overview
7.10.3 CBPO Blood Plasma Fractionation Technology Major Product Offerings
7.10.4 CBPO Blood Plasma Fractionation Technology Revenue in Global Market (2018-2023)
7.10.5 CBPO Key News & Latest Developments
7.11 Hualan Bio
7.11.1 Hualan Bio Company Summary
7.11.2 Hualan Bio Business Overview
7.11.3 Hualan Bio Blood Plasma Fractionation Technology Major Product Offerings
7.11.4 Hualan Bio Blood Plasma Fractionation Technology Revenue in Global Market (2018-2023)
7.11.5 Hualan Bio Key News & Latest Developments
7.12 Tiantan Bio
7.12.1 Tiantan Bio Company Summary
7.12.2 Tiantan Bio Business Overview
7.12.3 Tiantan Bio Blood Plasma Fractionation Technology Major Product Offerings
7.12.4 Tiantan Bio Blood Plasma Fractionation Technology Revenue in Global Market (2018-2023)
7.12.5 Tiantan Bio Key News & Latest Developments
7.13 Shuanglin Bio
7.13.1 Shuanglin Bio Company Summary
7.13.2 Shuanglin Bio Business Overview
7.13.3 Shuanglin Bio Blood Plasma Fractionation Technology Major Product Offerings
7.13.4 Shuanglin Bio Blood Plasma Fractionation Technology Revenue in Global Market (2018-2023)
7.13.5 Shuanglin Bio Key News & Latest Developments
7.14 Boya Bio
7.14.1 Boya Bio Company Summary
7.14.2 Boya Bio Business Overview
7.14.3 Boya Bio Blood Plasma Fractionation Technology Major Product Offerings
7.14.4 Boya Bio Blood Plasma Fractionation Technology Revenue in Global Market (2018-2023)
7.14.5 Boya Bio Key News & Latest Developments
7.15 Yuanda Shuyang
7.15.1 Yuanda Shuyang Company Summary
7.15.2 Yuanda Shuyang Business Overview
7.15.3 Yuanda Shuyang Blood Plasma Fractionation Technology Major Product Offerings
7.15.4 Yuanda Shuyang Blood Plasma Fractionation Technology Revenue in Global Market (2018-2023)
7.15.5 Yuanda Shuyang Key News & Latest Developments
7.16 Weiguang Bio
7.16.1 Weiguang Bio Company Summary
7.16.2 Weiguang Bio Business Overview
7.16.3 Weiguang Bio Blood Plasma Fractionation Technology Major Product Offerings
7.16.4 Weiguang Bio Blood Plasma Fractionation Technology Revenue in Global Market (2018-2023)
7.16.5 Weiguang Bio Key News & Latest Developments
7.17 Nanyue Bio
7.17.1 Nanyue Bio Company Summary
7.17.2 Nanyue Bio Business Overview
7.17.3 Nanyue Bio Blood Plasma Fractionation Technology Major Product Offerings
7.17.4 Nanyue Bio Blood Plasma Fractionation Technology Revenue in Global Market (2018-2023)
7.17.5 Nanyue Bio Key News & Latest Developments
7.18 KM Biologics
7.18.1 KM Biologics Company Summary
7.18.2 KM Biologics Business Overview
7.18.3 KM Biologics Blood Plasma Fractionation Technology Major Product Offerings
7.18.4 KM Biologics Blood Plasma Fractionation Technology Revenue in Global Market (2018-2023)
7.18.5 KM Biologics Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Blood Plasma Fractionation Technology Market Opportunities & Trends in Global Market
Table 2. Blood Plasma Fractionation Technology Market Drivers in Global Market
Table 3. Blood Plasma Fractionation Technology Market Restraints in Global Market
Table 4. Key Players of Blood Plasma Fractionation Technology in Global Market
Table 5. Top Blood Plasma Fractionation Technology Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Blood Plasma Fractionation Technology Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Blood Plasma Fractionation Technology Revenue Share by Companies, 2018-2023
Table 8. Global Companies Blood Plasma Fractionation Technology Product Type
Table 9. List of Global Tier 1 Blood Plasma Fractionation Technology Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Blood Plasma Fractionation Technology Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Blood Plasma Fractionation Technology Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Blood Plasma Fractionation Technology Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Blood Plasma Fractionation Technology Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global Blood Plasma Fractionation Technology Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Blood Plasma Fractionation Technology Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Blood Plasma Fractionation Technology Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global Blood Plasma Fractionation Technology Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Blood Plasma Fractionation Technology Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Blood Plasma Fractionation Technology Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Blood Plasma Fractionation Technology Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Blood Plasma Fractionation Technology Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Blood Plasma Fractionation Technology Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Blood Plasma Fractionation Technology Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Blood Plasma Fractionation Technology Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Blood Plasma Fractionation Technology Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Blood Plasma Fractionation Technology Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Blood Plasma Fractionation Technology Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Blood Plasma Fractionation Technology Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Blood Plasma Fractionation Technology Revenue, (US$, Mn), 2024-2029
Table 30. Takeda Company Summary
Table 31. Takeda Blood Plasma Fractionation Technology Product Offerings
Table 32. Takeda Blood Plasma Fractionation Technology Revenue (US$, Mn) & (2018-2023)
Table 33. Takeda Key News & Latest Developments
Table 34. CSL Company Summary
Table 35. CSL Blood Plasma Fractionation Technology Product Offerings
Table 36. CSL Blood Plasma Fractionation Technology Revenue (US$, Mn) & (2018-2023)
Table 37. CSL Key News & Latest Developments
Table 38. Grifols Company Summary
Table 39. Grifols Blood Plasma Fractionation Technology Product Offerings
Table 40. Grifols Blood Plasma Fractionation Technology Revenue (US$, Mn) & (2018-2023)
Table 41. Grifols Key News & Latest Developments
Table 42. Octapharma Company Summary
Table 43. Octapharma Blood Plasma Fractionation Technology Product Offerings
Table 44. Octapharma Blood Plasma Fractionation Technology Revenue (US$, Mn) & (2018-2023)
Table 45. Octapharma Key News & Latest Developments
Table 46. Kedrion Company Summary
Table 47. Kedrion Blood Plasma Fractionation Technology Product Offerings
Table 48. Kedrion Blood Plasma Fractionation Technology Revenue (US$, Mn) & (2018-2023)
Table 49. Kedrion Key News & Latest Developments
Table 50. LFB Group Company Summary
Table 51. LFB Group Blood Plasma Fractionation Technology Product Offerings
Table 52. LFB Group Blood Plasma Fractionation Technology Revenue (US$, Mn) & (2018-2023)
Table 53. LFB Group Key News & Latest Developments
Table 54. Biotest Company Summary
Table 55. Biotest Blood Plasma Fractionation Technology Product Offerings
Table 56. Biotest Blood Plasma Fractionation Technology Revenue (US$, Mn) & (2018-2023)
Table 57. Biotest Key News & Latest Developments
Table 58. BPL Company Summary
Table 59. BPL Blood Plasma Fractionation Technology Product Offerings
Table 60. BPL Blood Plasma Fractionation Technology Revenue (US$, Mn) & (2018-2023)
Table 61. BPL Key News & Latest Developments
Table 62. RAAS Company Summary
Table 63. RAAS Blood Plasma Fractionation Technology Product Offerings
Table 64. RAAS Blood Plasma Fractionation Technology Revenue (US$, Mn) & (2018-2023)
Table 65. RAAS Key News & Latest Developments
Table 66. CBPO Company Summary
Table 67. CBPO Blood Plasma Fractionation Technology Product Offerings
Table 68. CBPO Blood Plasma Fractionation Technology Revenue (US$, Mn) & (2018-2023)
Table 69. CBPO Key News & Latest Developments
Table 70. Hualan Bio Company Summary
Table 71. Hualan Bio Blood Plasma Fractionation Technology Product Offerings
Table 72. Hualan Bio Blood Plasma Fractionation Technology Revenue (US$, Mn) & (2018-2023)
Table 73. Hualan Bio Key News & Latest Developments
Table 74. Tiantan Bio Company Summary
Table 75. Tiantan Bio Blood Plasma Fractionation Technology Product Offerings
Table 76. Tiantan Bio Blood Plasma Fractionation Technology Revenue (US$, Mn) & (2018-2023)
Table 77. Tiantan Bio Key News & Latest Developments
Table 78. Shuanglin Bio Company Summary
Table 79. Shuanglin Bio Blood Plasma Fractionation Technology Product Offerings
Table 80. Shuanglin Bio Blood Plasma Fractionation Technology Revenue (US$, Mn) & (2018-2023)
Table 81. Shuanglin Bio Key News & Latest Developments
Table 82. Boya Bio Company Summary
Table 83. Boya Bio Blood Plasma Fractionation Technology Product Offerings
Table 84. Boya Bio Blood Plasma Fractionation Technology Revenue (US$, Mn) & (2018-2023)
Table 85. Boya Bio Key News & Latest Developments
Table 86. Yuanda Shuyang Company Summary
Table 87. Yuanda Shuyang Blood Plasma Fractionation Technology Product Offerings
Table 88. Yuanda Shuyang Blood Plasma Fractionation Technology Revenue (US$, Mn) & (2018-2023)
Table 89. Yuanda Shuyang Key News & Latest Developments
Table 90. Weiguang Bio Company Summary
Table 91. Weiguang Bio Blood Plasma Fractionation Technology Product Offerings
Table 92. Weiguang Bio Blood Plasma Fractionation Technology Revenue (US$, Mn) & (2018-2023)
Table 93. Weiguang Bio Key News & Latest Developments
Table 94. Nanyue Bio Company Summary
Table 95. Nanyue Bio Blood Plasma Fractionation Technology Product Offerings
Table 96. Nanyue Bio Blood Plasma Fractionation Technology Revenue (US$, Mn) & (2018-2023)
Table 97. Nanyue Bio Key News & Latest Developments
Table 98. KM Biologics Company Summary
Table 99. KM Biologics Blood Plasma Fractionation Technology Product Offerings
Table 100. KM Biologics Blood Plasma Fractionation Technology Revenue (US$, Mn) & (2018-2023)
Table 101. KM Biologics Key News & Latest Developments
List of Figures
Figure 1. Blood Plasma Fractionation Technology Segment by Type in 2022
Figure 2. Blood Plasma Fractionation Technology Segment by Application in 2022
Figure 3. Global Blood Plasma Fractionation Technology Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Blood Plasma Fractionation Technology Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Blood Plasma Fractionation Technology Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Blood Plasma Fractionation Technology Revenue in 2022
Figure 8. By Type - Global Blood Plasma Fractionation Technology Revenue Market Share, 2018-2029
Figure 9. By Application - Global Blood Plasma Fractionation Technology Revenue Market Share, 2018-2029
Figure 10. By Type - Global Blood Plasma Fractionation Technology Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Blood Plasma Fractionation Technology Revenue Market Share, 2018-2029
Figure 12. By Application - Global Blood Plasma Fractionation Technology Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Blood Plasma Fractionation Technology Revenue Market Share, 2018-2029
Figure 14. By Region - Global Blood Plasma Fractionation Technology Revenue Market Share, 2018-2029
Figure 15. By Country - North America Blood Plasma Fractionation Technology Revenue Market Share, 2018-2029
Figure 16. US Blood Plasma Fractionation Technology Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Blood Plasma Fractionation Technology Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Blood Plasma Fractionation Technology Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Blood Plasma Fractionation Technology Revenue Market Share, 2018-2029
Figure 20. Germany Blood Plasma Fractionation Technology Revenue, (US$, Mn), 2018-2029
Figure 21. France Blood Plasma Fractionation Technology Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Blood Plasma Fractionation Technology Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Blood Plasma Fractionation Technology Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Blood Plasma Fractionation Technology Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Blood Plasma Fractionation Technology Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Blood Plasma Fractionation Technology Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Blood Plasma Fractionation Technology Revenue Market Share, 2018-2029
Figure 28. China Blood Plasma Fractionation Technology Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Blood Plasma Fractionation Technology Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Blood Plasma Fractionation Technology Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Blood Plasma Fractionation Technology Revenue, (US$, Mn), 2018-2029
Figure 32. India Blood Plasma Fractionation Technology Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Blood Plasma Fractionation Technology Revenue Market Share, 2018-2029
Figure 34. Brazil Blood Plasma Fractionation Technology Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Blood Plasma Fractionation Technology Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Blood Plasma Fractionation Technology Revenue Market Share, 2018-2029
Figure 37. Turkey Blood Plasma Fractionation Technology Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Blood Plasma Fractionation Technology Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Blood Plasma Fractionation Technology Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Blood Plasma Fractionation Technology Revenue, (US$, Mn), 2018-2029
Figure 41. Takeda Blood Plasma Fractionation Technology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. CSL Blood Plasma Fractionation Technology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Grifols Blood Plasma Fractionation Technology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Octapharma Blood Plasma Fractionation Technology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Kedrion Blood Plasma Fractionation Technology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. LFB Group Blood Plasma Fractionation Technology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Biotest Blood Plasma Fractionation Technology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. BPL Blood Plasma Fractionation Technology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. RAAS Blood Plasma Fractionation Technology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. CBPO Blood Plasma Fractionation Technology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Hualan Bio Blood Plasma Fractionation Technology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Tiantan Bio Blood Plasma Fractionation Technology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Shuanglin Bio Blood Plasma Fractionation Technology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Boya Bio Blood Plasma Fractionation Technology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Yuanda Shuyang Blood Plasma Fractionation Technology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Weiguang Bio Blood Plasma Fractionation Technology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. Nanyue Bio Blood Plasma Fractionation Technology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 58. KM Biologics Blood Plasma Fractionation Technology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)



★調査レポート[世界の血漿分画技術市場予測2023-2029:アルブミン、免疫グロブリン、凝固因子、その他] (コード:MMG23FB2163)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の血漿分画技術市場予測2023-2029:アルブミン、免疫グロブリン、凝固因子、その他]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆